pharmaobservatory 0.1.4 → 0.1.6
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +118 -7
- data/docs/ApiV1WhoamiGet200Response.md +13 -1
- data/docs/ApiV1WhoamiGet200ResponseLimits.md +32 -0
- data/docs/ApiV1WhoamiGet200ResponseQuota.md +20 -0
- data/docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md +28 -0
- data/docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md +28 -0
- data/docs/BiomarkerAssayEvidenceResponse.md +58 -0
- data/docs/{BiomarkerCdxAssertionsResponseBuild.md → BiomarkerAssayEvidenceResponseBuild.md} +2 -2
- data/docs/{BiomarkerCdxAssertionsResponseFreshness.md → BiomarkerAssayEvidenceResponseFreshness.md} +2 -2
- data/docs/{BiomarkerCdxAssertionsResponseScope.md → BiomarkerAssayEvidenceResponseScope.md} +2 -2
- data/docs/BiomarkerAssayEvidenceRow.md +68 -0
- data/docs/BiomarkerAssayWhitespaceResponse.md +58 -0
- data/docs/BiomarkerAssayWhitespaceRow.md +66 -0
- data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
- data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
- data/docs/BiomarkerEvidenceResponse.md +3 -3
- data/docs/BiomarkerLiteratureResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesRow.md +9 -1
- data/docs/BiomarkerRelationsResponse.md +3 -3
- data/docs/BiomarkerSampleCoverageResponse.md +3 -3
- data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
- data/docs/BiomarkerValidationResponse.md +3 -3
- data/docs/BiomarkerVariantMentionsResponse.md +3 -3
- data/docs/BiomarkersApi.md +160 -0
- data/docs/BiomarkersRecord.md +2 -2
- data/docs/BiomarkersResponse.md +3 -3
- data/docs/BiomarkersRow.md +2 -0
- data/docs/CellLinesRecord.md +2 -2
- data/docs/CellLinesResponse.md +3 -3
- data/docs/CompaniesApi.md +246 -0
- data/docs/CompaniesRecord.md +2 -2
- data/docs/CompaniesResponse.md +3 -3
- data/docs/CompaniesRow.md +1 -1
- data/docs/CompanyAssetsResponse.md +3 -3
- data/docs/CompanyFundingEventsResponse.md +3 -3
- data/docs/CompanyFundingEventsRow.md +1 -1
- data/docs/CompanyFundingSummaryResponse.md +3 -3
- data/docs/CompanyMembersResponse.md +3 -3
- data/docs/CompanyProgramsResponse.md +3 -3
- data/docs/CompanyTargetsResponse.md +3 -3
- data/docs/CompanyTargetsRow.md +5 -1
- data/docs/ConditionAdverseEventsResponse.md +3 -3
- data/docs/ConditionBurdenResponse.md +3 -3
- data/docs/ConditionDeliveryResponse.md +3 -3
- data/docs/ConditionDrugsResponse.md +3 -3
- data/docs/ConditionPrevalenceResponse.md +3 -3
- data/docs/ConditionPrevalenceRow.md +1 -1
- data/docs/ConditionPublicationsResponse.md +3 -3
- data/docs/ConditionRecruitmentByPhaseResponse.md +58 -0
- data/docs/ConditionRecruitmentByPhaseRow.md +50 -0
- data/docs/ConditionRecruitmentDurationResponse.md +58 -0
- data/docs/ConditionRecruitmentDurationRow.md +86 -0
- data/docs/ConditionSitesResponse.md +3 -3
- data/docs/ConditionTrialStartForecastResponse.md +58 -0
- data/docs/ConditionTrialStartForecastRow.md +70 -0
- data/docs/ConditionTrialsResponse.md +3 -3
- data/docs/ConditionTrialsRow.md +4 -2
- data/docs/ConditionsApi.md +240 -0
- data/docs/ConditionsRecord.md +2 -2
- data/docs/ConditionsRecordAttributes.md +3 -1
- data/docs/ConditionsResponse.md +3 -3
- data/docs/DrugPatentCliffResponse.md +3 -3
- data/docs/InstitutionalHoldingsResponse.md +3 -3
- data/docs/InstitutionalHoldingsRow.md +7 -1
- data/docs/InvestorFundsResponse.md +58 -0
- data/docs/InvestorFundsRow.md +24 -0
- data/docs/InvestorPortfolioResponse.md +58 -0
- data/docs/InvestorPortfolioRow.md +42 -0
- data/docs/InvestorPrivateFundsResponse.md +58 -0
- data/docs/InvestorPrivateFundsRow.md +44 -0
- data/docs/InvestorsApi.md +633 -0
- data/docs/InvestorsRecord.md +38 -0
- data/docs/InvestorsResponse.md +58 -0
- data/docs/InvestorsRow.md +54 -0
- data/docs/LegalEntitiesApi.md +240 -0
- data/docs/LegalEntitiesRecord.md +2 -2
- data/docs/LegalEntitiesResponse.md +3 -3
- data/docs/LegalEntitiesRow.md +1 -1
- data/docs/ManagersApi.md +233 -0
- data/docs/ManagersRecord.md +38 -0
- data/docs/ManagersResponse.md +58 -0
- data/docs/ManagersRow.md +46 -0
- data/docs/OrgDisclosuresResponse.md +58 -0
- data/docs/OrgDisclosuresRow.md +56 -0
- data/docs/OrgRelationshipsResponse.md +58 -0
- data/docs/OrgRelationshipsRow.md +68 -0
- data/docs/OwnershipPositionsResponse.md +3 -3
- data/docs/OwnershipPositionsRow.md +16 -14
- data/docs/PdufaDatesResponse.md +3 -3
- data/docs/SiteBedsYearlyResponse.md +3 -3
- data/docs/SiteCroTrialsResponse.md +3 -3
- data/docs/SiteHospitalsResponse.md +3 -3
- data/docs/SiteInvestigatorsResponse.md +3 -3
- data/docs/SiteTrialConditionsResponse.md +3 -3
- data/docs/SiteTrialDrugsResponse.md +3 -3
- data/docs/SiteTrialsResponse.md +3 -3
- data/docs/SiteTrialsRow.md +3 -1
- data/docs/SitesRecord.md +2 -2
- data/docs/SitesResponse.md +3 -3
- data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
- data/docs/SponsorRecruitmentDurationResponse.md +3 -3
- data/docs/SponsorTrialStartForecastResponse.md +3 -3
- data/docs/SponsorTrialsResponse.md +3 -3
- data/docs/SponsorTrialsRow.md +4 -2
- data/docs/SupplierCapabilityEsgResponse.md +58 -0
- data/docs/SupplierCapabilityEsgRow.md +64 -0
- data/docs/SupplierServicesResponse.md +58 -0
- data/docs/SupplierServicesRow.md +30 -0
- data/docs/SupplierSitesResponse.md +58 -0
- data/docs/SupplierSitesRow.md +42 -0
- data/docs/SuppliersApi.md +313 -0
- data/docs/SuppliersRecord.md +38 -0
- data/docs/SuppliersResponse.md +58 -0
- data/docs/SuppliersRow.md +76 -0
- data/docs/TargetAssociationsResponse.md +58 -0
- data/docs/TargetAssociationsRow.md +26 -0
- data/docs/TargetCrowdingResponse.md +58 -0
- data/docs/TargetCrowdingRow.md +30 -0
- data/docs/TargetDrugsResponse.md +58 -0
- data/docs/TargetDrugsRow.md +38 -0
- data/docs/TargetEvidenceResponse.md +58 -0
- data/docs/TargetEvidenceRow.md +52 -0
- data/docs/TargetPatentMentionsResponse.md +58 -0
- data/docs/TargetPatentMentionsRow.md +34 -0
- data/docs/TargetProgramsResponse.md +58 -0
- data/docs/TargetProgramsRow.md +58 -0
- data/docs/TargetPublicationsResponse.md +58 -0
- data/docs/TargetPublicationsRow.md +32 -0
- data/docs/TargetRegulatoryPrecedentResponse.md +58 -0
- data/docs/TargetRegulatoryPrecedentRow.md +38 -0
- data/docs/TargetTrialsResponse.md +58 -0
- data/docs/TargetTrialsRow.md +46 -0
- data/docs/TargetsApi.md +1033 -0
- data/docs/TargetsRecord.md +38 -0
- data/docs/TargetsResponse.md +58 -0
- data/docs/TargetsRow.md +68 -0
- data/docs/TrialAdverseEventsResponse.md +3 -3
- data/docs/TrialChangesResponse.md +3 -3
- data/docs/TrialDeliveryResponse.md +3 -3
- data/docs/TrialDeliveryRow.md +7 -5
- data/docs/TrialDemographicsResponse.md +3 -3
- data/docs/TrialDrugClassesResponse.md +58 -0
- data/docs/TrialDrugClassesRow.md +28 -0
- data/docs/TrialDrugsResponse.md +3 -3
- data/docs/TrialEnrollmentHistoryResponse.md +3 -3
- data/docs/TrialEnrollmentRateResponse.md +3 -3
- data/docs/TrialEnrollmentRateRow.md +5 -3
- data/docs/TrialExtractedEndpointsResponse.md +3 -3
- data/docs/TrialKolsResponse.md +58 -0
- data/docs/TrialKolsRow.md +32 -0
- data/docs/TrialOutcomeMeasuresResponse.md +3 -3
- data/docs/TrialResearchPaymentsResponse.md +58 -0
- data/docs/TrialResearchPaymentsRow.md +44 -0
- data/docs/TrialSiteHistoryResponse.md +58 -0
- data/docs/TrialSiteHistoryRow.md +50 -0
- data/docs/TrialSitesResponse.md +3 -3
- data/docs/TrialsApi.md +320 -0
- data/docs/TrialsRecord.md +2 -2
- data/docs/TrialsResponse.md +3 -3
- data/docs/TrialsRow.md +3 -3
- data/lib/pharmaobservatory/api/biomarkers_api.rb +168 -0
- data/lib/pharmaobservatory/api/companies_api.rb +273 -0
- data/lib/pharmaobservatory/api/conditions_api.rb +252 -0
- data/lib/pharmaobservatory/api/investors_api.rb +665 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +252 -0
- data/lib/pharmaobservatory/api/managers_api.rb +245 -0
- data/lib/pharmaobservatory/api/suppliers_api.rb +329 -0
- data/lib/pharmaobservatory/api/targets_api.rb +1085 -0
- data/lib/pharmaobservatory/api/trials_api.rb +336 -0
- data/lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb +62 -4
- data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_limits.rb +419 -0
- data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota.rb +263 -0
- data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets.rb +367 -0
- data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets_requests_per_minute.rb +367 -0
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +478 -0
- data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_build.rb → biomarker_assay_evidence_response_build.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_freshness.rb → biomarker_assay_evidence_response_freshness.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_scope.rb → biomarker_assay_evidence_response_scope.rb} +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb +506 -0
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb +499 -0
- data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_row.rb +49 -5
- data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
- data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_row.rb +12 -1
- data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
- data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_record.rb +2 -2
- data/lib/pharmaobservatory/models/companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_row.rb +1 -1
- data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_events_row.rb +1 -1
- data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_targets_row.rb +27 -5
- data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_prevalence_row.rb +1 -1
- data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_row.rb +399 -0
- data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_recruitment_duration_row.rb +597 -0
- data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_row.rb +509 -0
- data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trials_row.rb +14 -3
- data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
- data/lib/pharmaobservatory/models/conditions_record_attributes.rb +13 -4
- data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_row.rb +35 -2
- data/lib/pharmaobservatory/models/investor_funds_response.rb +478 -0
- data/lib/pharmaobservatory/models/investor_funds_row.rb +256 -0
- data/lib/pharmaobservatory/models/investor_portfolio_response.rb +478 -0
- data/lib/pharmaobservatory/models/investor_portfolio_row.rb +357 -0
- data/lib/pharmaobservatory/models/investor_private_funds_response.rb +478 -0
- data/lib/pharmaobservatory/models/investor_private_funds_row.rb +366 -0
- data/lib/pharmaobservatory/models/investors_record.rb +385 -0
- data/lib/pharmaobservatory/models/investors_response.rb +478 -0
- data/lib/pharmaobservatory/models/investors_row.rb +421 -0
- data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
- data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
- data/lib/pharmaobservatory/models/legal_entities_row.rb +1 -1
- data/lib/pharmaobservatory/models/managers_record.rb +385 -0
- data/lib/pharmaobservatory/models/managers_response.rb +478 -0
- data/lib/pharmaobservatory/models/managers_row.rb +377 -0
- data/lib/pharmaobservatory/models/org_disclosures_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_disclosures_row.rb +432 -0
- data/lib/pharmaobservatory/models/org_relationships_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_relationships_row.rb +498 -0
- data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_positions_row.rb +26 -15
- data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trials_row.rb +13 -2
- data/lib/pharmaobservatory/models/sites_record.rb +2 -2
- data/lib/pharmaobservatory/models/sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_row.rb +14 -3
- data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +478 -0
- data/lib/pharmaobservatory/models/supplier_capability_esg_row.rb +480 -0
- data/lib/pharmaobservatory/models/supplier_services_response.rb +478 -0
- data/lib/pharmaobservatory/models/supplier_services_row.rb +289 -0
- data/lib/pharmaobservatory/models/supplier_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/supplier_sites_row.rb +357 -0
- data/lib/pharmaobservatory/models/suppliers_record.rb +385 -0
- data/lib/pharmaobservatory/models/suppliers_response.rb +478 -0
- data/lib/pharmaobservatory/models/suppliers_row.rb +544 -0
- data/lib/pharmaobservatory/models/target_associations_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_associations_row.rb +267 -0
- data/lib/pharmaobservatory/models/target_crowding_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_crowding_row.rb +289 -0
- data/lib/pharmaobservatory/models/target_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_drugs_row.rb +335 -0
- data/lib/pharmaobservatory/models/target_evidence_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_evidence_row.rb +410 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_row.rb +311 -0
- data/lib/pharmaobservatory/models/target_programs_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_programs_row.rb +447 -0
- data/lib/pharmaobservatory/models/target_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_publications_row.rb +300 -0
- data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_regulatory_precedent_row.rb +333 -0
- data/lib/pharmaobservatory/models/target_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_trials_row.rb +377 -0
- data/lib/pharmaobservatory/models/targets_record.rb +385 -0
- data/lib/pharmaobservatory/models/targets_response.rb +478 -0
- data/lib/pharmaobservatory/models/targets_row.rb +498 -0
- data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_delivery_row.rb +22 -11
- data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_drug_classes_row.rb +278 -0
- data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_rate_row.rb +15 -4
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_kols_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_kols_row.rb +302 -0
- data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_research_payments_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_research_payments_row.rb +366 -0
- data/lib/pharmaobservatory/models/trial_site_history_response.rb +478 -0
- data/lib/pharmaobservatory/models/trial_site_history_row.rb +401 -0
- data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/trials_record.rb +2 -2
- data/lib/pharmaobservatory/models/trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/trials_row.rb +3 -3
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +75 -3
- metadata +152 -8
|
@@ -0,0 +1,38 @@
|
|
|
1
|
+
# PharmaObservatory::TargetRegulatoryPrecedentRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **target_id** | **String** | The target's Ensembl gene id (ENSG followed by eleven digits): the entry key for the targets object type. A gene symbol is not a value here; it is a separate column. | [optional] |
|
|
8
|
+
| **target_symbol** | **String** | The target's HGNC gene symbol (the id the target page address carries). | [optional] |
|
|
9
|
+
| **drug_id** | **String** | The drug's canonical id (the same id the drug datasets use as drug_id). | [optional] |
|
|
10
|
+
| **drug_name** | **String** | The drug's name. | [optional] |
|
|
11
|
+
| **authority** | **String** | The approving authority. | [optional] |
|
|
12
|
+
| **jurisdiction** | **String** | The authority's jurisdiction. | [optional] |
|
|
13
|
+
| **status** | **String** | The approval status the authority records. | [optional] |
|
|
14
|
+
| **first_approval_date** | **Date** | The authority's first approval date of the drug. | [optional] |
|
|
15
|
+
| **approval_id** | **String** | The authority's own approval identifier. | [optional] |
|
|
16
|
+
| **primary_action_type** | **String** | The action type of the drug's curated mechanism on the target. | [optional] |
|
|
17
|
+
| **moa_evidence_source** | **String** | The evidence tier of the mechanism; curated_moa on every row. | [optional] |
|
|
18
|
+
|
|
19
|
+
## Example
|
|
20
|
+
|
|
21
|
+
```ruby
|
|
22
|
+
require 'pharmaobservatory'
|
|
23
|
+
|
|
24
|
+
instance = PharmaObservatory::TargetRegulatoryPrecedentRow.new(
|
|
25
|
+
target_id: null,
|
|
26
|
+
target_symbol: null,
|
|
27
|
+
drug_id: null,
|
|
28
|
+
drug_name: null,
|
|
29
|
+
authority: null,
|
|
30
|
+
jurisdiction: null,
|
|
31
|
+
status: null,
|
|
32
|
+
first_approval_date: null,
|
|
33
|
+
approval_id: null,
|
|
34
|
+
primary_action_type: null,
|
|
35
|
+
moa_evidence_source: null
|
|
36
|
+
)
|
|
37
|
+
```
|
|
38
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::TargetTrialsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<TargetTrialsRow>**](TargetTrialsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::TargetTrialsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,46 @@
|
|
|
1
|
+
# PharmaObservatory::TargetTrialsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **target_id** | **String** | The target's Ensembl gene id (ENSG followed by eleven digits): the entry key for the targets object type. A gene symbol is not a value here; it is a separate column. | [optional] |
|
|
8
|
+
| **target_symbol** | **String** | The target's HGNC gene symbol (the id the target page address carries). | [optional] |
|
|
9
|
+
| **trial_id** | **String** | The ClinicalTrials.gov NCT id, the id the trials datasets use. | [optional] |
|
|
10
|
+
| **evidence_source** | **String** | The best evidence tier among the trial's drugs that act on the target. | [optional] |
|
|
11
|
+
| **brief_title** | **String** | The trial's brief title. | [optional] |
|
|
12
|
+
| **phase** | **String** | The registry's phase code (PHASE1, PHASE2, PHASE2/PHASE3, NA and so on). Null when the registry gives no phase (observational and expanded-access trials); phase_label carries the display label for those. | [optional] |
|
|
13
|
+
| **phase_label** | **String** | The trial phase as a display label (Phase 2, Phase 3, Observational, Not applicable, Expanded access, Unknown). The same trial's phase column holds the registry code. | [optional] |
|
|
14
|
+
| **overall_status** | **String** | The registry's overall recruitment status. | [optional] |
|
|
15
|
+
| **start_year** | **Integer** | The year the trial started. | [optional] |
|
|
16
|
+
| **lead_sponsor_name** | **String** | The lead sponsor's name as filed. | [optional] |
|
|
17
|
+
| **lead_sponsor_org_id** | **String** | Legal-entity level: the lead sponsor organization; null when it does not resolve. | [optional] |
|
|
18
|
+
| **lead_sponsor_company_id** | **String** | Company level: the lead sponsor's company; null when none. | [optional] |
|
|
19
|
+
| **lead_sponsor_company_name** | **String** | Display name of the lead sponsor's company. | [optional] |
|
|
20
|
+
| **lead_sponsor_group_id** | **String** | Group level: the lead sponsor's current ultimate parent company; a root company's group is itself. | [optional] |
|
|
21
|
+
| **lead_sponsor_group_name** | **String** | Display name of the lead sponsor's group. | [optional] |
|
|
22
|
+
|
|
23
|
+
## Example
|
|
24
|
+
|
|
25
|
+
```ruby
|
|
26
|
+
require 'pharmaobservatory'
|
|
27
|
+
|
|
28
|
+
instance = PharmaObservatory::TargetTrialsRow.new(
|
|
29
|
+
target_id: null,
|
|
30
|
+
target_symbol: null,
|
|
31
|
+
trial_id: null,
|
|
32
|
+
evidence_source: null,
|
|
33
|
+
brief_title: null,
|
|
34
|
+
phase: null,
|
|
35
|
+
phase_label: null,
|
|
36
|
+
overall_status: null,
|
|
37
|
+
start_year: null,
|
|
38
|
+
lead_sponsor_name: null,
|
|
39
|
+
lead_sponsor_org_id: null,
|
|
40
|
+
lead_sponsor_company_id: null,
|
|
41
|
+
lead_sponsor_company_name: null,
|
|
42
|
+
lead_sponsor_group_id: null,
|
|
43
|
+
lead_sponsor_group_name: null
|
|
44
|
+
)
|
|
45
|
+
```
|
|
46
|
+
|